This suggests that passive immunization with tau antibodies is actually a practical therapeutic concentrate on and that the CSF standard of p-tau262/356 or of your microtubule binding domain (MTBD) can function a helpful biomarker of tau pathology to monitor tau therapeutics in scientific trials.